A COA can support commercial source approval for a semiconductor wet chemical only when it belongs to the exact grade, manufacturing and filling configuration, commercial package, and specification being qualified—and when its methods can evaluate the buyer’s application-critical limits. For HCl, H₂SO₄, NH₄OH, H₂O₂, and single-component cleaning solvents such as IPA, assay or concentration alone cannot establish contamination control or delivered condition. If method capability, final-package identity, or representative commercial-lot evidence is missing, the correct decision is conditional approval or hold. The next step is a commercial-source evidence review using the buyer’s purchasing specification, the supplier’s matched COA, method information, and intended package.

This page answers one question for supplier-qualification teams: can the proposed commercial source be approved? It does not define routine incoming-lot release. Here, the source means the exact chemical identity and concentration, grade, manufacturing or purification site, final filtration and filling route, and intended commercial package. The scope is limited to liquid chemicals used in wafer cleaning, wet etching, surface conditioning, residue removal, or drying. It does not apply unchanged to CMP slurries, photoresists, formulated removers, plating baths, electronic gases, or solid precursors. ChemicalCell’s semiconductor wet-process chemical qualification framework covers the wider relationship between process function, contamination, delivery, and long-term control.

What Can a COA Prove Before Commercial Source Approval?

A COA is batch-specific evidence. When its identity and traceability are complete, it can show:

• which product and lot were reported;
• which attributes were included;
• which results were obtained or reported;
• whether those results met the specification associated with that COA.

It does not independently prove that:

• the supplier’s limits match the buyer’s process requirements;
• the method can measure reliably at the buyer’s limit;
• the sample was taken after final filtration and commercial filling;
• the evaluated package represents the proposed commercial package;
• the material will perform inside the buyer’s process window;
• routine commercial lots will reproduce the evaluated result;
• future changes will remain inside the original qualification boundary.

The evidence required for source approval is therefore:

Application Requirement → Purchasing Specification → Capable Method → Representative Commercial Material → Approval

A COA that cannot be connected across this chain may still support document screening. It should not be used by itself to grant unrestricted commercial source approval.

Define the Exact Commercial Source Before Comparing Results

The approved object should be recorded as:

Chemical + Concentration + Grade + Manufacturing/Purification Site + Final Filtration/Filling Route + Commercial Package

The quotation, specification, sample label, COA, and commercial proposal should all describe this same object. A shared chemical name or CAS number is insufficient.

For example, two HCl supplies may have the same CAS number while differing in concentration, impurity specification, production site, filling route, or package. Two IPA products may report similar assay while differing in water, nonvolatile residue, trace-organic profile, metals, particles, or sample origin. These differences do not automatically make one source unacceptable. They determine which evidence can be transferred and which evidence must be generated again.

Commercial approval should remain on hold when the proposed site, grade, filling route, or package is undefined. A very low impurity value cannot compensate for an unidentified or unrepresentative sample.

Which Variables Change the Approval Decision?

The necessary evidence depends on what the chemical does in the process and how an unacceptable variable can reach the wafer or another contamination-sensitive surface.

The rows are not interchangeable. Water is a critical impurity or composition variable for many cleaning solvents, but it should not be copied as the same purchasing criterion for an aqueous acid or base. An H₂O₂ release result must be interpreted with the qualified time, storage, and package boundary; an IPA result must be interpreted with solvent-specific sampling and residue risks.

SEMI C30 standardizes grades and supporting test procedures for hydrogen peroxide used in the semiconductor industry. SEMI C41 does so for 2-propanol. These standards provide chemical-specific reference bases; they do not establish that a particular supplier, package, or result satisfies a buyer’s process-specific purchasing specification.

Which COA Results Can Be Compared Directly?

Two values can be ranked only after the buyer aligns the measurand, method capability, reporting basis, and sample identity.

“ND” Does Not Mean Zero

“Not detected” is useful only when the governing detection or reporting threshold is known and is low enough to evaluate the purchasing limit. LOD, LOQ, method detection limit, and reporting limit can describe different points in a measurement and reporting system; the buyer should identify which one governs the result and release decision.

SEMI C10 provides guidance for determining method detection limits for trace contaminants in SEMI process-chemical specifications and states that the MDL used for that purpose should be at or below the relevant specification. Accordingly, “ND” without a defined threshold cannot demonstrate compliance with a lower buyer limit.

“Pass” Cannot Be Ranked Against a Numerical Result

“Pass” indicates that a supplier applied its release rule. It does not show the result’s distance from the limit, support trend review, or establish that another supplier measured on the same basis. For an approval-critical attribute, request an actual result or a defined less-than value when the method and reporting system support it.

Particle Results Require a Traceable Measurement Path

A particle value can support source approval only when the size channels, units, sampling position, commercial-package relationship, and blank pathway are known. ChemicalCell’s guide to electronic-grade particle report review explains why cumulative and differential channels, online and offline sampling, and container contributions cannot be compared automatically.

When Is an Evaluation Sample Required?

Document comparison may be sufficient to decide whether a proposed source is technically reviewable. It is not sufficient when the COA attributes cannot fully protect an application-critical process result.

An evaluation sample should be required when, for example:

• the buyer must confirm cleaning, etching, drying, residue, or material-compatibility behavior;
• supplier methods cannot be mapped confidently to the buyer’s existing data;
• the impurity profile differs in a way that cannot be judged from total purity;
• the proposed source is being evaluated as a second source against an approved material.

The application test should identify the sample lot, process condition, comparator, acceptance criterion, and failure response. A passed R&D sample demonstrates suitability under those test conditions. It does not approve a different filling route or commercial package.

When Is Representative Commercial-Lot Evidence Required?

Unrestricted commercial source approval should require representative commercial material when the qualification sample does not already reflect the intended manufacturing, final filtration, filling, and packaging configuration.

The commercial evidence should answer:

1. Is this the same grade, site, and process boundary evaluated during screening?
2. Was the sample taken from, or technically bridged to, the intended filling route and package?
3. Do approval-critical results use comparable methods and reporting limits?
4. Does any required application confirmation remain inside the approved process window?

If only the package or filling route changes, repeat the tests affected by that change rather than the entire qualification program. Water, particles, selected metals, ions, NVR, or package-derived organics may be affected depending on the material and contact system. ChemicalCell’s guide to qualifying electronic cleaning solvents when sample and bulk packaging differ provides the narrower packaging-equivalence decision.

There is no universal number of commercial lots required for every material. One representative lot can confirm the proposed commercial configuration; additional lots may be necessary when the buyer needs evidence of variation, the process risk is high, or the qualification protocol requires a broader basis. Multi-lot data strengthen a consistency judgment but cannot replace change control.

Approve, Conditionally Approve, Hold, or Reject?

The decision applies to the exact commercial source configuration. It does not automatically release every future incoming lot.

A documentation gap should normally lead to a hold, not an unsupported conclusion that the chemical is defective. Rejection requires a confirmed failure or a risk that remains unacceptable after the relevant evidence has been reviewed.

Which Changes Require Requalification?

Requalification is required when a supplier change makes part of the original approval evidence uncertain. The response should follow the affected pathway:

• Analytical method, reporting limit, or sampling point: establish method comparability and repeat the affected measurements where necessary.
• Final filter, filling route, commercial package, closure, or wetted component: review the contamination or stability pathway and obtain targeted final-package evidence.
• Manufacturing or purification site, process, or critical raw-material source: reassess the affected impurity profile, concentration or stability controls, and application evidence.
• Specification, grade, or qualified storage condition: compare the new boundary with the approved purchasing requirement before continued use.

The governing logic is:

Supplier Change → Evidence No Longer Transferable → Targeted Requalification → Revised Approval Boundary

An administrative document correction does not require chemical requalification when no technical evidence changes. A new production site normally affects a wider qualification boundary than a reporting-format update.

What Should Be Included in a Commercial-Source Qualification RFQ?

The next step is one qualification-ready RFQ for the exact commercial source, not a general request for “electronic grade.” Include only the information needed to resolve the approval gap:

• chemical name, CAS number, concentration or required grade, and intended wet-process step;
• application-critical limits and any required method, unit, or reporting basis;
• current qualification stage and intended commercial package;
• required quantity and destination;
• the existing COA or purchasing specification, with the missing evidence identified.

Request the applicable supplier specification and revision, a representative COA for the proposed configuration, method-capability information for approval-critical attributes, and the appropriate evaluation-sample or commercial-lot evidence. State which site, filling, package, method, or specification changes require notification.

When submitting a ChemicalCell chemical product RFQ, attach the available COA or target purchasing specification and identify the qualification evidence that must be confirmed. Availability of a particular chemical, electronic grade, package, sample, analytical report, or commercial-lot data should be confirmed for the specific inquiry.

The approval question is therefore precise: does the evidence define and support the exact commercial source that will enter the intended semiconductor wet process? If not, the buyer should identify the missing link and request that evidence before approval.